Analysts at Bank of America assumed coverage on shares of Afya (NASDAQ:AFYA) in a research report issued to clients and investors on Tuesday, MarketBeat.com reports. The firm set a “buy” rating and a $29.00 price target on the stock. Bank of America‘s target price indicates a potential upside of 19.64% from the company’s previous close.
Separately, JPMorgan Chase & Co. started coverage on shares of Afya in a research report on Friday, August 9th. They set an “overweight” rating and a $34.00 price objective for the company.
Afya stock opened at $24.24 on Tuesday. Afya has a 12-month low of $22.00 and a 12-month high of $29.37.
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company provides educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Featured Story: Dead Cat Bounce
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.